Palo Alto, CA, United States of America

Timothy W Meyer

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Cv Therapeutics, Inc.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Timothy W Meyer. Retrieved from https://idiyas.com/inventor/timothy-w-meyer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Timothy W. Meyer

Introduction

Timothy W. Meyer is a notable inventor based in Palo Alto, CA. He has made significant contributions to the field of medical technology, particularly in the treatment of kidney diseases. His innovative approach has led to the development of a unique method that utilizes antisense oligonucleotides for therapeutic purposes.

Latest Patents

Timothy W. Meyer holds 1 patent for his invention titled "Kidney Na/PO.sub.4 cotransporter antisense oligonucleotide." This invention focuses on a method for treating diseases that affect the mammalian kidney proximal tubule epithelium. It employs naked antisense oligonucleotides and antisense compositions targeting the mRNA of mammalian kidney epithelial proteins.

Career Highlights

Meyer is currently associated with Cv Therapeutics, Inc., where he continues to advance his research and innovations. His work has been instrumental in developing new therapeutic strategies for kidney-related ailments.

Collaborations

Throughout his career, Timothy has collaborated with esteemed colleagues such as Rainer Oberbauer and George Frederic Schreiner. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Timothy W. Meyer exemplifies the spirit of innovation in the medical field, particularly through his work on kidney treatments. His contributions are paving the way for new therapeutic options that could significantly improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…